Skip to main content

Stephen Worsley

Indi Molecular has named Stephen Worsley its senior VP of business development. Worsley joins the firm from Peregrine Pharmaceuticals, where he served as VP of business development. Earlier, he held the post of chief business officer at Centrose Pharmaceutical, and he was VP of business development for Intrexon, among other similar positions at a variety of biotech firms.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.